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Abstract
Background: Biological reconstruction surgery is a tough but alluring option for treating primary malignant
musculoskeletal tumors. In this article, we evaluate the clinical outcomes of primary malignant musculoskeletal
tumors treated with inactivated autograft using alcohol.
Method: In this article, we include 58 patients who had primary malignant bone tumors treated with wide
resection and recycling autograft reconstruction using alcohol between January 2003 and January 2013. The
outcomes were measured by recurrence, functional status, and complications. Functional status was assessed
according to the Musculoskeletal Tumor Society Score (MSTSS). The Kaplan-Meier survival curve was used to
evaluate the survival rate of the patient.
Result: The most common tumor was osteosarcoma (31 cases) followed by chondrosarcoma (10 cases). The tibia
was the most frequently involved skeletal site (27 cases) followed by femur (26 cases). The median follow-up period
was 54 months, ranging from 18 to 96 months. In 58 patients, 12 were with local recurrence (20.7 %), 16 with lung
metastasis (27.6 %), and 13 with complications (22.4 %). The main complication was infection (8 cases). The
autografts survived in 49 patients (84.5 %). The mean MSTSS score was 78.5 %, ranging from 47 to 98 %.
Conclusion: Recycling autograft reconstruction using alcohol had favorable clinical outcomes to some degree;
however, the recurrence and complication rates seem to be high. Thus, we should apply this method with caution
and choose the patients with strict surgical indication.
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Background
Malignant bone tumors have characteristics of high
degree of malignancy and high rates of recurrence,
morbidity, and early metastasis. Since the 1970s, with
the advances in diagnostic imaging, chemo- and
radiotherapy, and operative techniques, limb salvage
surgery has become a preferred choice for malignant
bone tumor [1].
Wide resection and limb salvage surgery are considered
a standard treatment for primary malignant musculoskel-
etal tumors [2–4]. Compared with amputation, limb
salvage surgery did not reduce survival rate. In contrast, it
achieved lower rate of local recurrence and retained part
of limb function [5]. The options for reconstruction
following tumor excision include endoprostheses [6],
allografting [7], composite arthroplasty [8], and dis-
traction osteogenesis [9]. Tumor prosthesis recon-
struction gives the most favorable clinical result in
terms of functional outcome and complication rates.
However, endoprosthesis has the limitation of long-
term survival of prosthesis and high cost. Unfortu-
nately, most patients in developing countries cannot
afford this type of reconstruction and are treated with
amputation. Biological limb salvage procedures are
considered an alternative treatment for patients who
cannot afford endoprosthesis. Recycling of the resected
segment is one type of biological reconstruction. Several
methods have been applied including autoclaving [10],
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freezing [11], pasteurization [12], extracorporeal irradi-
ation [13], and alcohol inactivation [14, 15]. In China, we
primarily choose inactivated autograft using alcohol to
carry out biological limb salvage procedures. The method
has several advantages, with material easily obtained,
economic, no rejection, and low infection rate.
However, there still remain some serious problems.
The aim of this study was to evaluate the long-term
outcome following the use of this method and then
put forward some constructive advice to optimize it.
Patients and methods
This was a single-centered and retrospective study
approved by the Ethics Committee of Shanghai Jiao
Tong University Affiliated Sixth People’s Hospital. All
procedures were in compliance with the Helsinki Declar-
ation. Informed consent for participation was obtained
from all participants in this study. We reviewed 58 pa-
tients who had a primary malignant bone tumor treated
with wide resection and autograft reconstruction using
alcohol. The operation was performed between January
2003 and January 2013 (Table 1).
The mean follow-up period for the patients was
54.3 months (18–96). Of the 58 cases (33 men), the
most common tumor was osteosarcoma (31 cases)
followed by chondrosarcoma (10 cases); the tibia was the
most frequently involved skeletal site (27 cases) followed
by the femur (26 cases). All had a histological diagnosis
based on incisional biopsy (Table 2).
The primary tumor was evaluated on plain radio-
graphs, computed tomography (CT) scans, and magnetic
resonance imaging scans. The bone scintigraphy and CT
scanning of the chest were performed to confirm that
there were no metastases. All the patients received the
2–3 circles of standard three-course neoadjuvant
chemotherapy with a 3-week interval between cycles.
After receiving the full course of neoadjuvant chemo-
therapy, all the patients were restaged using MRI and
received surgery 2 weeks after the last course. Postop-
erative chemotherapy (1 circle) was performed every
month and lasted for 12 to 18 months.
Operative technique
Wide resection was performed on all patients. The level
of resection was determined by the preoperative MRI
(restaging MRI) and an intraoperative fluoroscopic
image. The surgical technique was described as follows:
(1) the lesion was resected according to tumor-free tech-
nique rules—dissociating the tumor 2–3 cm apart from
the reaction zone and truncating the bone 5 cm from
the lesion. (2) The soft tissue and extraosseous tumor
were cleared off, with the essential ligaments, like the
collateral and lateral ligaments of the knee, retained. (3)
The bone lesion was removed by bistrique and the
remaining bone was immerged into 99 % alcohol for
30 min, then retrieved and flushed with 3000 ml
physiological saline. (4) Kirschner combining with
bone cement was used to fill the bone defects, and
the final fixation was performed using the steel plate or
intramedullary nail. Postoperative plaster immobilization
was applied for 2 months and then removed. Patients were
encouraged to do functional training with initial protec-
tion of the brace.
Statistical analysis
Limb function was evaluated with the Musculoskeletal
Tumor Society (MSTS) rating scales, which comprise
six items, namely, pain, function, emotional accept-
ance, support, walking, and gait. Five points are allo-
cated to each item and the highest score is 30
(100 %) [16]. Autografts that were functional and
conserved were deemed as “survived,” and those that
had been removed or had resorbed and were no
longer functional were recorded “died.” Survival of
patients was recorded using the Kaplan-Meier method
with 95 % confidence interval.
Results
The mean survival period was 75.2 months (60–90),
and 25 patients were alive and tumor-free, of which
16 osteosarcoma, 6 chondrosarcoma, 2 giant cell
tumor of bone, and 1 mucus chondrosarcoma. Thus,
the 5-year survival rate was 43.1 % (Fig. 1). Sixteen
patients died of lung metastasis, of which 9 patients
had local recurrence and lung metastasis (two pa-
tients received postoperative amputation and resection
of lung metastatic foci). Eleven patients died of
complications including infection, cachexia, and renal
failure. Four patients died of other diseases and two
patients died of adverse reaction of chemotherapy
(Table 3). The mean MSTSS score was 78.5 % ran-
ging from 47 to 98 %. Forty-nine autografts survived
and nine died for several reasons including infection,
necrosis, and absorption. In 58 patients, 3 were with
local recurrence (5.2 %), 7 with lung metastasis
(12.1 %), and 9 with both local and lung metastases
(15.5 %).
Complications were encountered in 13 of 58 pa-
tients (22.4 %), including deep infection in 8 (13.8 %),
flap necrosis in 3 (5.2 %), fracture and nonunion in 3
(5.2 %), and joint dislocation in 2 (3.4 %) (Table 4).
Eight patients with deep infection were managed by
debridement, drainage, irrigation, and the use of anti-
biotics. The inactivated autograft was removed in two
patients with deep infection. All the three local flap
necrosis occurred in the proximal tibia, of which two
cases healed after debridement and drainage and one
case was with the infection out of control due to the
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Table 1 Details of patients who underwent reconstruction with inactivated autograft treated with alcohol
Case Gender and age(Y) Location Stagea Histology Length, cm Resection MSTSS score ,% Outcomes Follow-up (months)
1 M/12 DF IIB OSA 15 IA 81 Death 29
2 M/16 PT IIB OSA 18 IA 92 DF 61
3 F/21 PT IIB CHOS 21 IA 95 DF 70
4 M/12 DF IIB OSA 17 IA 81 DF 78
5 F/13 PT IIB OSA 23 IC 73 DF 69
6 F/17 PT IIB OSA 16 IA 85 DF 73
7 M/2O PF IIB SSA 25 IA 69 Death 23
8 M/16 DF IB OSA 18 IC 67 DF 90
9 M/32 PT IIB CHOS 16 IA 98 DF 84
10 F/11 PH IB OSA 27 IA 87 DF 96
11 F/15 SH IIB 0SA 21 IC 89 Death 40
12 M/19 DF IIB SSA 15 EA 72 Death 43
13 M/14 DF IIB EWS 18 IC 78 Death 48
14 M/23 PT IIB CHOS 19 IA 91 DF 72
15 M/17 PF IIB OSA 31 IA 76 DF 68
16 F/13 DF IIB OSA 22 EA 80 Death 55
17 F/19 PT IB IGTB 19 IC 77 DF 88
18 M/39 PT IB CHOS 17 IA 96 Death 56
19 M/26 DF IIB CHOS 22 IA 72 DF 60
20 M/21 PT IIB MCHOS 23 IA 94 DF 62
21 F/15 DF IIB OSA 28 IA 85 Death 36
22 F/14 PF IB IGTB 24 IA 70 Death 29
23 M/15 PT IIB OSA 16 IC 87 DF 70
24 M/26 DF IIB MCHOS 17 IA 85 Death 18
25 F/18 PT IIB OSA 19 IC 78 DF 79
26 M/2O DF IIB FSA 18 IA 67 Death 28
27 F/13 DF IIB EWS 30 IA 54 Death 41
28 F/16 PT IB OSA 21 IA 86 Death 38
29 M/25 PT IIB CHOS 25 IA 74 DF 64
30 M/17 PH IIB OSA 17 EA 47 Death 28
31 F/12 DF IB OSA 19 IA 86 DF 65
32 M/15 PT IIB IGTB 23 IA 95 DF 96
33 M/19 DF IIB FSA 29 IA 82 Death 29
34 F/22 PT IIB MCHOS 22 IA 83 Death 38
35 F/13 DF IB OSA 25 IC 70 DF 80
36 M/18 PT IIB OSA 18 EA 93 Death 34
37 F/45 DF IIB CHOS 15 IA 85 DF 70
38 F/16 PT IIB 0SA 19 IA 67 DF 66
39 M/19 DF IIB SSA 21 IA 94 Death 53
40 M/13 PT IIB MFCT 29 IA 73 Death 48
41 M/21 DF IB CHOS 18 IC 49 Death 36
42 M/14 PH IIB OSA 16 IA 85 Death 52
43 M/19 DF IIB OSA 14 IA 79 DF 78
44 M/2O PT IB MCHOS 19 IA 70 Death 30
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patient automatically discharging from hospital. One
patient with fracture of the autograft (due to trauma)
was treated with secondary internal fixation. Two
patients with fracture of steel plate received conser-
vative treatment. Two patients with joint dislocation
received prompt treatment. One was managed by
resetting the joint and then with the plaster
immobilization. The other was treated with removing
the autograft and then filling the defects with bone
cement instead.
Discussion
Most bone tumor patients are young; thus, the treat-
ments are supposed to not only preserve the limb but
also maintain function without major complications or
recurrences over long term [17, 18]. From a developing
nation’s perspective, reimplantation of extracorporeally
devitalized tumor-bearing bone segments is an appealing
option. It allows immediate and anatomical correct
filling of the defect [19]. Means of devitalizing tumor-
bearing bone varies, including autoclaving, freezing,
pasteurization, and extracorporeal irradiation. All the
methods have similar effect in killing the tumor cells.
However, the main differences lie in their effect on
mechanical properties of the bone [20].
Since the first report of inactivated autograft (using
alcohol) in the treatment of primary malignant mus-
culoskeletal tumor by Song X. W. in 1983 [21], the
method has been widely applied in hospitals through-
out China. It has various advantages including low
cost, no rejection or transmission of disease, no re-
quirement for a bone bank or for special equipment,
good fit between graft and host bone, and easy
attachment of tendons and ligaments to the bone. In
fact, it met the expectation of both the patients and
the doctors, and some patients achieved decent long-
term limb function [15, 22, 23]. However, this method
was not well applied due to no uniform standard of
selecting patients. Some patients that did not meet
the criteria of limb salvage surgery were proposed to
take this procedure, resulting in the failure of limb
salvage, thus increasing the incidence of complications
of the surgery objectively.
The bone shell inactivated by alcohol was almost
dead. When it was replanted back to the host com-
bining with bone cement, it takes more time to attach
to the normal soft tissue and bone compared with
the fresh one [24]. In the sites containing little soft
tissue, like the proximal tibia, it is inevitably to be
Table 1 Details of patients who underwent reconstruction with inactivated autograft treated with alcohol (Continued)
45 F/12 DF IIB OSA 21 IA 81 Death 42
46 F/17 PT IIB OSA 29 IA 58 Death 23
47 M/15 PT IIB OSA 31 IA 84 DF 88
48 M/21 DF IB MCHOS 17 IA 78 Death 55
49 F/16 PH IIB OSA 19 IC 59 Death 28
50 F/19 PT IIB SSA 21 IA 80 Death 34
51 F/11 DF IIB OSA 27 IA 71 Death 33
52 F/17 PT IIB OSA 22 IA 97 DF 82
53 M/38 PT IB CHOS 25 IA 71 Death 46
54 M/12 DF IIB OSA 17 IC 93 Death 58
55 M/15 PT IIB MFCT 19 IA 48 Death 19
56 F/11 DF IIB OSA 26 IA 75 DF 72
57 F/24 PT IB CHOS 19 IC 79 Death 46
58 M/13 PT IIB SSA 17 IA 83 Death 55
DF distal femur, PF proximal femur, PH proximal humerus, PT proximal tibia, SH shaft humerus, OSA osteosarcoma, CHOS chondrosarcoma, MCHOS mucus
chondrosarcoma, FSA fibrosarcoma, EWS Ewing’s sarcoma, IGTB invasive giant cell tumor of bone, MFCT malignant fibrous cell tumors, SSA synovial sarcoma,
EA extra-articular, IA intra-articular, IC intercalary, DF disease free
aEnneking surgical stage
Table 2 Histological diagnosis of inactivated autografts used as
reconstruction after the excision of a tumor
Histological diagnosis No. of patients (n = 58)
Osteosarcoma OSA 31
Chondrosarcoma CHOS 10
Mucus chondrosarcoma MCHOS 5
Fibrosarcoma FSA 2
Ewing’s sarcoma EWS 2
Invasive giant cell tumor of bone IGTB 2
Malignant fibrous cell tumors MFCT 2
Synovial sarcoma SSA 4
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infected with the flap necrosis after the resection of
tumor. In 11 patients with infection or flap necrosis,
9 occurred in the proximal tibia. There were several
tips in coping with this situation. First, it is necessary
to retain enough soft tissue; if not, the flap transfer-
ring surgery should been performed (the medial head
of the gastrocnemius is most frequently used). Sec-
ond, preoperative prophylactic use of antibiotics is
essential and should be continued for a period time.
Third, it is advisable to minimize the use of electric
knife in resecting lesions next to the normal flap and
avoid excessive traction of the flap. Fourth, adequate
postoperative drainage is of great importance; thus, it
is preferable to place unilateral or bilateral subcutane-
ous drainage strips and cover the gauze with
pressure.
Though the tumor-bearing bone is autologous, it is in-
deed “dead” after the inactivation of alcohol. The healing
process is similar to that of allograft, mainly through
Fig. 1 The 5-year survival rate. The mean survival period was 75.2 months (60–90), and 25 patients were alive and tumor-free, of which
16 osteosarcoma, 6 chondrosarcoma, 2 giant cell tumor of bone, and 1 mucus chondrosarcoma. Thus, the 5-year survival rate was 43.1 %.
Sixteen patients died of lung metastasis, of which nine patients had local recurrence and lung metastasis (two patients received postoperative
amputation and resection of lung metastatic foci). Eleven patients died of complications including infection, cachexia, and renal failure.
Four patients died of other diseases and two patients died of reaction of chemotherapy
Table 3 Complications of inactivated autograft treated with
alcohol
Types (of complication) No. (rates)
Early complications 11 (18.9 %)
Infection 8
Flap necrosis 3
Late complications 5 (8.6 %)
Fracture and union 3
Dislocation 2
Total 13 (22.4. %)
Table 4 Outcomes of patients treated with inactivated autograft
induced by alcohol
Types No. (rates)






Reactions of chemotherapy 2
Other diseases 4
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creeping substitution of host bone and infiltration of
mesenchymal cells of soft tissue [25]. Therefore, this is a
long-period process that some researchers believe to be
3 to 5 years [26]. One patient in our group experienced
fracture due to trauma 6 years after the surgery. Intri-
guingly, when taking biopsy of the intraoperative cortical
bone in the fracture site, it turned out to be without
bone formation. However, the tumor-bearing bone still
contained some active inducible factors for the limited
penetration of alcohol, so the inactivated autograft takes
less time to union compared with allograft [24]. In
former animal experiments on the biomechanics and
healing process of alcohol-inactivated bone, we found
that the healing process initiated in the bone ends,
followed by the middle section (which had the weakest
mechanical strength in the late phase of healing) [26].
Therefore, to avoid fractures, the patients should not
bear too much weight before complete clinical healing.
For patients with fracture, secondary surgery of internal
fixation was proposed if conditions are permitting.
Otherwise, the conservative treatment was the wise
choice. Different techniques have been proposed to
reduce complications and improve functions of the
affected extremities [27–29].
It was of great importance to enact replantation indi-
cations [15, 17, 30]. In our group, 12 cases were with
local recurrence, of which 8 cases were the result of in-
appropriate selection of patients. Two patients with huge
soft tissue mass showing poor response to chemotherapy
were requested by their families to conduct limb salvage
surgery, resulting in the failure of extensive resection of
the tumor and subsequent recurrence 6 months later.
The flap necrosis and infection occurred in a patient
(with tumor in the proximal tibia) for retaining little soft
Fig. 2 Case presentation I. Case 43: A 19-year-old man was diagnosed as having osteosarcoma in the distal of his left femur and was treated
with wide resection and inactivated autograft using alcohol. a Plain radiography before surgery. b MRI before surgery. c Inactivated autograft by
alcohol in surgery. d Three months after surgery. e One year after surgery. f Two years after surgery
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tissue to cover the bone after surgery. Hence, selection
criteria can affect the prognosis of patients and efficacy
of limb salvage surgery directly. Our inclusion criteria of
limb salvage surgery include the following: (I) tumors
were sensitive to chemotherapy; (II) a limited boundary
of the tumor; (III) good conditions for local soft tissue;
(IV) a relative intact continuity of the resected bone; and
(V) a good general condition, with no occurrence of
other serious diseases. Patients with large tumors,
unclear boundary, extensive invasion of soft tissue, or
involvement of major blood vessels and nerves or who
are insensitive to chemotherapy, cannot afford chemo-
therapy costs, or are reluctant to finish chemotherapy
should be excluded.
Joint dislocation occurred mainly in the knee, which
related to poor- or non-healing of ligament reconstruc-
tion [31]. The residual ligaments on inactivated autograft
were “dead”, and the initial connection with normal ones
was strengthened by sutures. The full healing of ligament
could maintain a certain tension, preventing excessive
sliding of the joint. If the reconstructed ligaments were
absorbed or not healed, then the joint dislocation might
occur. For patients with knee reconstruction and in-
creased activity should be taken under the protection of
brace. As for dislocation, closed reduction was the best
choice. If the joints are dislocated for a long time, with the
soft tissue contracted, the open reduction was proposed.
For patients having difficulties in resetting the joint, the
temporary support was essential until the secondary
surgery with allograft or prosthesis.
Whether it was a semi-autogenous-inactivated joint
replantation or a semi-allogeneic one, articular cartilage
degeneration inevitably happened [32, 33]. The degree of
degeneration was positively related to growing age, high
frequency of exercise, long timespan after surgery, etc.
In our group, patients receiving amputation in the
secondary surgery showed serious degeneration of
articular cartilage in postoperative anatomical specimens.
Therefore, there is no effective method in alleviating the
progression and degree of degeneration.
The long-term outcome of our patients was poor due
to multiple reasons, including the subjective and objective
ones. For objective ones, it was inevitable. However, it was
possible to eliminate the subjective ones. The latter
Fig. 3 Case presentation II. Case 37: A 45-year-old woman was diagnosed as having chondrosarcoma in the distal of her left femur and was
treated with wide resection and inactivated autograft using alcohol. a Plain radiography before surgery. b MRI before surgery. c Inactivated
autograft by alcohol in surgery. d Three months after surgery. e One year after surgery. f Two years after surgery
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patients of this group were screened strictly in accordance
with the selecting criteria, and only four cases were with
local recurrence. For patients who survived for a long
term, the biological reconstruction using alcohol-
inactivated autograft was an economic and effective alter-
native. In our group, some patients got a good outcome
with a full heeling of autograft (Figs. 2 and 3). Anyway, all
methods have their unfavorable aspects. Considering the
relative high complication rates of this method, patients
with indication of limb salvage can choose endoprosthetic
treatment if it was economically affordable. For patients
with lung metastasis, intensive involvement of vital vessels
and nerves, or poor response to chemotherapy, amputa-
tion should be performed without hesitation.
Conclusions
We find in this study that recycling autograft reconstruc-
tion using alcohol had favorable clinical outcomes to some
extent. However, the rates of complications increased due
to inappropriate selection of patients in the early period.
After strictly adhering to indications of limb salvage, the
rates decreased drastically. Therefore, the method should
be used with caution in several aspects, especially in the
indication of limb salvage surgery.
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